Rankings
▼
Calendar
ACET Q4 2015 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena
ACET
Adicet Bio, Inc.
$69M
Q4 2015 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$132M
Gross Profit
$36M
27.2% margin
Operating Income
$14M
10.7% margin
Net Income
$8M
6.3% margin
EPS (Diluted)
$5.12
Cash Flow
Operating Cash Flow
$13M
Free Cash Flow
$13M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$524M
Total Liabilities
$239M
Stockholders' Equity
$286M
Cash & Equivalents
$54M
Revenue Segments
Human Health
$59M
45%
Performance Chemicals
$38M
29%
Pharmaceutical Ingredients
$34M
26%
← FY 2015
All Quarters
Q1 2016 →
